1. Home
  2. VCIC vs SMTI Comparison

VCIC vs SMTI Comparison

Compare VCIC & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCIC
  • SMTI
  • Stock Information
  • Founded
  • VCIC 2024
  • SMTI 1982
  • Country
  • VCIC United States
  • SMTI United States
  • Employees
  • VCIC N/A
  • SMTI 108
  • Industry
  • VCIC
  • SMTI Medical/Dental Instruments
  • Sector
  • VCIC
  • SMTI Health Care
  • Exchange
  • VCIC NYSE
  • SMTI Nasdaq
  • Market Cap
  • VCIC 297.4M
  • SMTI 297.2M
  • IPO Year
  • VCIC 2024
  • SMTI N/A
  • Fundamental
  • Price
  • VCIC $10.14
  • SMTI $34.65
  • Analyst Decision
  • VCIC
  • SMTI Strong Buy
  • Analyst Count
  • VCIC 0
  • SMTI 2
  • Target Price
  • VCIC N/A
  • SMTI $47.00
  • AVG Volume (30 Days)
  • VCIC 1.4K
  • SMTI 22.3K
  • Earning Date
  • VCIC 01-01-0001
  • SMTI 05-12-2025
  • Dividend Yield
  • VCIC N/A
  • SMTI N/A
  • EPS Growth
  • VCIC N/A
  • SMTI N/A
  • EPS
  • VCIC N/A
  • SMTI N/A
  • Revenue
  • VCIC N/A
  • SMTI $78,056,873.00
  • Revenue This Year
  • VCIC N/A
  • SMTI $35.26
  • Revenue Next Year
  • VCIC N/A
  • SMTI $20.79
  • P/E Ratio
  • VCIC N/A
  • SMTI N/A
  • Revenue Growth
  • VCIC N/A
  • SMTI 24.66
  • 52 Week Low
  • VCIC $9.96
  • SMTI $26.00
  • 52 Week High
  • VCIC $10.16
  • SMTI $39.08
  • Technical
  • Relative Strength Index (RSI)
  • VCIC N/A
  • SMTI 55.23
  • Support Level
  • VCIC N/A
  • SMTI $30.81
  • Resistance Level
  • VCIC N/A
  • SMTI $32.90
  • Average True Range (ATR)
  • VCIC 0.00
  • SMTI 1.43
  • MACD
  • VCIC 0.00
  • SMTI 0.20
  • Stochastic Oscillator
  • VCIC 0.00
  • SMTI 87.77

About VCIC VINE HILL CAP INVT CORP

Vine Hill Capital Investment Corp is a blank check company.

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.

Share on Social Networks: